MOLECULES AND CELLS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2023-02-12 ms8000000030832967 来自重庆

第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2022-06-01 神的女儿

偏重的研究方向：心肌;干细胞分化
经验分享：2022-5-6 投稿Awaiting EM processing
2022-5-11 Awaiting AE Checklist，Awaiting AE Decision
2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment
2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores
期待好结果

102 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2019-01-27 千千寻

一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢

176 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2021-04-28 ms8000000589777671

版面费2250美元一页，慎重

65 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2022-05-17 146708f8m11暂无昵称

请问有没有接收之后一直收不到proof的，一直在拖

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2020-08-27 146c2e54m01(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：细胞生物学;血管生物学
经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄

103 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

选择期刊时应该注意什么？

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

选刊的流程是什么？

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2018-03-28 1212661cm75暂无昵称

审稿速度:12.0 | 投稿命中率:5.0
经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!

269 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114235, encodeId=1a2a2114235a7, content=第一次一审一个月遇到两个很专业的审稿人，提了大概30+建议或意见编辑建议大修重投认真修改后重新提交刚好遇到放假两个月左右还没结果邮件联系说第一次审稿的专家没有空审稿重新找审稿人然后这次审稿人一个全部yes，一个有两个must improve，一个yes，两个can be improve，然后编辑就拒稿了。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sun Feb 12 14:23:26 CST 2023, time=2023-02-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1223821, encodeId=b7ec122382149, content=偏重的研究方向：心肌;干细胞分化 经验分享：2022-5-6 投稿Awaiting EM processing 2022-5-11 Awaiting AE Checklist，Awaiting AE Decision 2022-5-28 Awaiting AE Decision，Awaiting Reviewer Assignment 2022-5-31 催稿信当天状态变为 Awaiting AE Decision，Awaiting Reviewer Scores 期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21935563242, createdName=神的女儿, createdTime=Wed Jun 01 11:17:19 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566207, encodeId=2e4856620e2e, content=一审意见小修，但给了三个月，请问你们一般给了多久时间返修？如果我一个月后返回去。会不会太快不妥当？为了毕业。。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67cf1976059, createdName=千千寻, createdTime=Sun Jan 27 00:00:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961217, encodeId=d0d496121e94, content=版面费2250美元一页，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=861b5486649, createdName=ms8000000589777671, createdTime=Wed Apr 28 15:18:13 CST 2021, time=2021-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220307, encodeId=6f39122030e50, content=请问有没有接收之后一直收不到proof的，一直在拖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f17e5138898, createdName=146708f8m11暂无昵称, createdTime=Tue May 17 15:40:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813851, encodeId=315b8138515f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物学;血管生物学 经验分享：我是4月3号投稿，5月初才under review，6月底才修回，两个审稿人，问题都很简单，审稿人建议补实验，疫情的影响没有补，仔细解释了不补原因（现有结果就可以说明，疫情的影响无法补），7月初就返回去了，半个月左右，只是补充了一些试验方法。7月底就显示接收了。总体来说杂志审稿不是特别快，但是意见没有那么刻薄 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c525164375, createdName=146c2e54m01(暂无昵称), createdTime=Thu Aug 27 08:41:52 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095328, encodeId=72bb109532885, content=选择期刊时应该注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095327, encodeId=91d8109532ec1, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554245, encodeId=879f5542450f, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：千万不要投!千万不要投!千万不要投!重要的话说三遍! 本人2017年9月投过去.guide上写的半个月给一审回复.呵呵了.一个多月才送审.然后直到今天.也就是接近2018年4月了才回复一审意见. 中间共花了接近8个月.中间催过三次稿.没有任何回复.逗我呢??? 最后回复的意见里.没有任何解释为什么拖了这么久给出的两个审稿意见都是积极向上的.要求的revise也很少.算是两个小修. 居然.给拒了! 第一次见这样的.这么不负责任! 真的叫投出去了就石沉大海的感觉.压根没法儿和编辑联系上.连argue都没有途径.真心服了韩国人的杂志.韩国就这样???辣鸡! 大家引以为戒.浪费时间!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d872232076, createdName=1212661cm75暂无昵称, createdTime=Wed Mar 28 00:00:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055731, encodeId=bf901055e31fa, content=偏重的研究方向：细胞生物学 经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Sep 28 16:23:07 CST 2021, time=2021-09-28, status=1, ipAttribution=)]

2021-09-28 JayNi

偏重的研究方向：细胞生物学
经验分享：这个杂志真心不负责，感觉有点垃圾。审稿速度也还行，最后Decision 一直持续了一个月，结果发了封邮件查询下，五分钟拒稿。一看审稿人意见一个小修一个大修，杂志的拒稿意见就是不符合要求，真是醉了

64 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务